PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$36.64 USD
+0.12 (0.33%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $36.39 -0.25 (-0.68%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/24/2024
Time: -- |
9/2024 | $-1.53 | 0.00% |
Earnings Summary
For their last quarter, PTC Therapeutics (PTCT) reported earnings of -$1.16 per share, missing the Zacks Consensus Estimate of -$1.00 per share. This reflects a negative earnings surprise of 16.00%. Look out for PTCT's next earnings release expected on October 24, 2024. For the next earning release, we expect the company to report earnings of -$1.53 per share, reflecting a year-over-year increase of 13.07%.
Earnings History
Price & Consensus
Zacks News for PTCT
Unlocking Q2 Potential of PTC Therapeutics (PTCT): Exploring Wall Street Estimates for Key Metrics
PTCT: What are Zacks experts saying now?
Zacks Private Portfolio Services